Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
6159448 | The Journal of Urology | 2012 | 6 Pages |
Abstract
Cyclosporine A had a high success rate for patients with Hunner lesions in whom more conservative options, including endoscopic treatment, had failed. The success rate was low for patients without Hunner lesions. A 3 to 4-month trial is sufficient time to assess response. Adverse events were common and led to discontinuation of cyclosporine A for some patients. Close monitoring is needed, especially for blood pressure and renal function.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Nephrology
Authors
John B. Forrest, Christopher K. Payne, Deborah R. Erickson,